Vyant Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Leasing Arrangements (Tables)

6 Months Ended

Jun. 30, 2019

The components of lease expense were as follows for the three and six months ended June 30, 2019 for continuing operations (in thousands):

Supplemental cash flow related to leases of our continuing operations was as follows for the three and six months ended June 30, 2019 (in thousands):



	Three months ended June 30, 2019		Six months ended June 30, 2019
Cash paid amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	55	$	110

Other supplemental information related to leases of our continuing operations was as follows for the six months ended June 30, 2019:



Weighted average remaining lease term (in years)
Operating leases	1.49

Weighted average discount rate
Operating leases	7.96	%

At June 30, 2019, future estimated minimum lease payments under non-cancelable operating leases were as follows (in thousands):



2019 (remaining 6 months)	$	94
2020	209
2021	12
Total minimum lease payments	315
Less amount representing interest	30
Total	$	285